Botox Owns the Market for Now
When I think of Botox, I think of that song that reminds me of these words, “Sitting on top of the world.” What a feeling for the executives at California-based Allergan Corporation. With a stock trading at over $100 a share and no near term competition for now, it’s easy to feel that you are sitting on top of the world. For now anyway.
If the trial results are positive for Reloxin, expect this drug to be on the market sometime in 2008. In no way would we conclude that the FTC has any influence over the FDA. However, it was only last year that Allergan and the Inamed Corporation settled Federal Trade Commission charges that Allergan’s $3.2 billion purchase of Inamed would violate federal antitrust laws by divesting the rights to develop and distribute Reloxin.The license to market Reloxin is now owned by Medicis Pharmaceutical Corp.
What is Reloxin? Like Botox, Reloxin is a Botulinum Toxin Type A product. It’s sold in sold in over 60 countries by Ipsen under the trademark DYSPORT® for various therapeutic indications and is approved in 9 countries for cosmetic indications. Here is what some are saying about the coming of Reloxin. It has a higher dispersion, which means that the muscle contraction at the point of injection is relaxed, but so too, is a more of the surrounding area for an overall relaxed and younger you.
February 5th, 2009 at 8:03 pm
I love Botox - had it at Aspen Medical Aesthetics and Laser Clinic in Mequon - results were GREAT - I am addicted! Glad I started it now - when I am 38 - help my wrinkles now before they are even worse and harder to treat! GREAT doctor and wonderful staff - I was VERY comfortable!
Tammy